Lin-Ya Guo

Plasma Pharmacokinetics and Tissue Distribution of Doxorubicin in Rats following Treatment with Astragali Radix

Yan Xu, Zunjian Zhang, Xiaxia Yu, 2022, Pharmaceuticals.

Attenuation of doxorubicin-induced oxidative damage in rat brain by regulating amino acid homeostasis with Astragali Radix

Fengguo Xu, Yuan Tian, Zunjian Zhang, 2021, Amino Acids.

Identification of region-specific amino acid signatures for doxorubicin-induced chemo brain

Xiaxia Yu, Yan Yu, Yin Huang, 2023, Amino acids.

Metabolic network-based identification of plasma markers for non-small cell lung cancer

Fengguo Xu, Yuan Tian, Zunjian Zhang, 2021, Analytical and Bioanalytical Chemistry.

Study on multi-target effects of PIMPC on Aβ/Cu2+-induced Alzheimer's disease model of rats

Ping Liu, Dan Wu, Yanan Zhao, 2022, Brain Research.

Identification and validation of a prognostic model for melanoma patients with 9 ferroptosis-related gene signature

Jie-cong Wang, Zi-Ying Zhou, Lin-Ya Guo, 2022, BMC Genomics.

Quantification of 10 B vitamins in mouse colon by LC-MS/MS: Application on breast cancer mice treated with doxorubicin.

Lin-Ya Guo, Xinyue Yu, Jiahong Yang, 2023, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Network-driven targeted analysis reveals that Astragali Radix alleviates doxorubicin-induced cardiotoxicity by maintaining fatty acid homeostasis.

Xueyang Deng, Fengguo Xu, Zunjian Zhang, 2022, Journal of ethnopharmacology.

CXCL2, a new critical factor and therapeutic target for cardiovascular diseases

Ai-Ping Wang, Lijun Peng, Fang Yang, 2019, Clinical and experimental hypertension.

Metabolomics and Network Analyses Reveal Phenylalanine and Tyrosine as Signatures of Anthracycline-Induced Hepatotoxicity

Jing Wu, Yin Huang, Ling Zhao, 2023, Pharmaceuticals.

Bioinformatic identification of potential biomarkers and therapeutic targets in carotid atherosclerosis and vascular dementia

Xintong Liu, Dongshi Li, Lin-Ya Guo, 2023, Frontiers in Neurology.